Sarasota Memorial’s Kolschowsky Research and Education Institute is part of an international clinical trial that may provide a new treatment option for those with advanced stage squamous cell skin cancer, one of the most common types of skin cancer, often found in areas exposed to the sun, such as the head, neck and arms. The Phase III study is evaluating whether adding an immunotherapy drug before surgery results in better outcomes, especially for those with fast-growing lesions that have a higher rate of recurrence or spreading to other parts of the body.